...
首页> 外文期刊>The Lancet >Blood pressure and incidence of twelve cardiovascular diseases: Lifetime risks, healthy life-years lost, and age-specific associations in 1·25 million people
【24h】

Blood pressure and incidence of twelve cardiovascular diseases: Lifetime risks, healthy life-years lost, and age-specific associations in 1·25 million people

机译:12个心血管疾病的血压和发病率:终身风险,健康寿命损失,以及1·2500万人的年龄特定协会

获取原文
获取原文并翻译 | 示例
           

摘要

Background The associations of blood pressure with the different manifestations of incident cardiovascular disease in a contemporary population have not been compared. In this study, we aimed to analyse the associations of blood pressure with 12 different presentations of cardiovascular disease. Methods We used linked electronic health records from 1997 to 2010 in the CALIBER (CArdiovascular research using LInked Bespoke studies and Electronic health Records) programme to assemble a cohort of 1·25 million patients, 30 years of age or older and initially free from cardiovascular disease, a fifth of whom received blood pressure-lowering treatments. We studied the heterogeneity in the age-specific associations of clinically measured blood pressure with 12 acute and chronic cardiovascular diseases, and estimated the lifetime risks (up to 95 years of age) and cardiovascular disease-free life-years lost adjusted for other risk factors at index ages 30, 60, and 80 years. This study is registered at ClinicalTrials.gov, number NCT01164371. Findings During 5·2 years median follow-up, we recorded 83 098 initial cardiovascular disease presentations. In each age group, the lowest risk for cardiovascular disease was in people with systolic blood pressure of 90-114 mm Hg and diastolic blood pressure of 60-74 mm Hg, with no evidence of a J-shaped increased risk at lower blood pressures. The effect of high blood pressure varied by cardiovascular disease endpoint, from strongly positive to no effect. Associations with high systolic blood pressure were strongest for intracerebral haemorrhage (hazard ratio 1·44 [95% CI 1·32-1·58]), subarachnoid haemorrhage (1·43 [1·25-1·63]), and stable angina (1·41 [1·36-1·46]), and weakest for abdominal aortic aneurysm (1·08 [1·00-1·17]). Compared with diastolic blood pressure, raised systolic blood pressure had a greater effect on angina, myocardial infarction, and peripheral arterial disease, whereas raised diastolic blood pressure had a greater effect on abdominal aortic aneurysm than did raised systolic pressure. Pulse pressure associations were inverse for abdominal aortic aneurysm (HR per 10 mm Hg 0·91 [95% CI 0·86-0·98]) and strongest for peripheral arterial disease (1·23 [1·20- 1·27]). People with hypertension (blood pressure ≥140/90 mm Hg or those receiving blood pressure-lowering drugs) had a lifetime risk of overall cardiovascular disease at 30 years of age of 63·3% (95% CI 62·9-63·8) compared with 46·1% (45·5-46·8) for those with normal blood pressure, and developed cardiovascular disease 5·0 years earlier (95% CI 4·8-5·2). Stable and unstable angina accounted for most (43%) of the cardiovascular disease-free years of life lost associated with hypertension from index age 30 years, whereas heart failure and stable angina accounted for the largest proportion (19% each) of years of life lost from index age 80 years. Interpretation The widely held assumptions that blood pressure has strong associations with the occurrence of all cardiovascular diseases across a wide age range, and that diastolic and systolic associations are concordant, are not supported by the findings of this high-resolution study. Despite modern treatments, the lifetime burden of hypertension is substantial. These findings emphasise the need for new blood pressure-lowering strategies, and will help to inform the design of randomised trials to assess them. Funding Medical Research Council, National Institute for Health Research, and Wellcome Trust.
机译:背景与当代人群的不同表现突发心血管疾病的血压协会并没有进行比较。在这项研究中,我们的目的是分析血压协会与心血管疾病的12个不​​同的演示。方法采用在CALIBER联电子健康记录1997年至2010年计划组装1名·21万名患者,30岁以上的老年人和队列心血管疾病开始免费(使用链接的定制研究和电子健康记录心血管研究)人,其中的第五接收降血压治疗。我们研究在临床上测量的血压与12急性和慢性心血管疾病的年龄别协会的异质性,并推测的寿命风险(高达95岁)和心血管无病生存年失去了调整其他危险因素在指数年龄30,60和80年。这项研究被注册在ClinicalTrials.gov,数量NCT01164371。调查结果在5。2年中位随访,我们记录了83点098初始心血管疾病的介绍。在各年龄组中,心血管疾病的风险最低的是人与90-114毫米汞柱的收缩压和60-74毫米汞柱的舒张压,在较低的血压没有一个J形风险增加的证据。高血压的效果变化,由心血管疾病终点,从强阳性没有效果。具有高收缩压协会是最强的为脑出血(风险比1·44 [95%CI 1·32-1·58]),蛛网膜下腔出血(1·43 [1·25-1·63]),和稳定的心绞痛(1·41 [1·36-1·46]),和最弱为腹主动脉瘤(1·08 [1·00-1·17])。与舒张压相比,升高收缩压对心绞痛,心肌梗死和外周动脉疾病的影响更大,而提出舒张压对腹主动脉瘤比没有提出收缩压的影响更大。脉压协会被腹主动脉瘤逆(每10毫米汞柱0·91 [95%CI 0·86-0·98] HR)和最强为外周动脉疾病(1·23 [1·20-1·27] )。高血压(血压≥140/ 90毫米汞柱或那些接收的降血压药物)的人在30年的63·3%(95%CI 62岁有整体心血管疾病的终生风险·9-63·8 )46·1%(45·5-46·8),用于那些具有正常血压,并且开发心血管疾病5·0年前(95%CI比较4·8-5·2)。稳定和不稳定型心绞痛占心血管疾病,无生命年的最多(43%)失去了与从指数年龄30岁高血压有关,而心脏衰竭和稳定型心绞痛占年生活的最大比例(各19%)从指数80岁失去。解读普遍持有假设血压具有在很宽的年龄范围内的所有心血管疾病的发生强相关,而收缩压和舒张压协会是一致的,不受该高分辨率的研究结果的支持。尽管现代的治疗,高血压的寿命负担是巨大的。这些发现强调了新的降血压战略的需要,并有助于通知的随机试验的设计,以评估它们。资助医学研究理事会,美国国家卫生研究所和威康信托基金会。

著录项

  • 来源
    《The Lancet》 |2014年第9932期|共13页
  • 作者单位

    Farr Institute of Health Informatics Research 222 Euston Road London NW1 2DA United Kingdom;

    Farr Institute of Health Informatics Research 222 Euston Road London NW1 2DA United Kingdom;

    Farr Institute of Health Informatics Research 222 Euston Road London NW1 2DA United Kingdom;

    Farr Institute of Health Informatics Research 222 Euston Road London NW1 2DA United Kingdom;

    Farr Institute of Health Informatics Research 222 Euston Road London NW1 2DA United Kingdom;

    Farr Institute of Health Informatics Research 222 Euston Road London NW1 2DA United Kingdom;

    MRC Biostatistics Unit Cambridge United Kingdom;

    Farr Institute of Health Informatics Research 222 Euston Road London NW1 2DA United Kingdom;

    Farr Institute of Health Informatics Research 222 Euston Road London NW1 2DA United Kingdom;

    Farr Institute of Health Informatics Research 222 Euston Road London NW1 2DA United Kingdom;

    Farr Institute of Health Informatics Research 222 Euston Road London NW1 2DA United Kingdom;

    Farr Institute of Health Informatics Research 222 Euston Road London NW1 2DA United Kingdom;

    Farr Institute of Health Informatics Research 222 Euston Road London NW1 2DA United Kingdom;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 医药、卫生;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号